scholarly article | Q13442814 |
P356 | DOI | 10.1211/0022357056631 |
P698 | PubMed publication ID | 16102254 |
P50 | author | Patrick F Augustijns | Q52125594 |
Joachim Brouwers | Q55590424 | ||
P2093 | author name string | Jan Tack | |
Françoise Ingels | |||
P2860 | cites work | The role of gamma-scintigraphy in oral drug delivery | Q34190329 |
Variability of gastrointestinal transit in healthy women and men. | Q34410247 | ||
Simultaneous measurement of antroduodenal motility, gastric emptying, and duodenogastric reflux in man | Q34476055 | ||
The gastric response to a transpyloric duodenal tube | Q34477183 | ||
Examination of the solubilization of drugs by bile salt micelles | Q34736775 | ||
Intestinal drug transporters: in vivo function and clinical importance. | Q35668185 | ||
Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in the stomach, duodenum and jejunum | Q42531032 | ||
Direct estimation of the in vivo dissolution of spironolactone, in two particle size ranges, using the single-pass perfusion technique (Loc-I-Gut) in humans | Q42638823 | ||
Cause of high variability in drug dissolution testing and its impact on setting tolerances | Q43511633 | ||
Prediction of plasma concentration-time curve of orally administered theophylline based on a scintigraphic monitoring of gastrointestinal transit in human volunteers | Q43919792 | ||
Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo | Q44447168 | ||
Can the USP paddle method be used to represent in-vivo hydrodynamics? | Q44476284 | ||
Contributions of CYP3A4, P-glycoprotein, and serum protein binding to the intestinal first-pass extraction of saquinavir | Q44725431 | ||
Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations | Q44755740 | ||
A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea | Q45031731 | ||
Characterization of fluids from the stomach and proximal jejunum in men and women. | Q50956608 | ||
Hydrodynamics-induced variability in the USP apparatus II dissolution test. | Q51537587 | ||
Dissolution of hydrocortisone in human and simulated intestinal fluids. | Q51557252 | ||
Biopharmaceutical characterization of oral theophylline and aminophylline tablets. Quantitative correlation between dissolution and bioavailability studies. | Q52074786 | ||
A comparison between direct determination of in vivo dissolution and the deconvolution technique in humans. | Q52222033 | ||
A comparison of the solubility of danazol in human and simulated gastrointestinal fluids | Q58199142 | ||
P433 | issue | 8 | |
P304 | page(s) | 987-996 | |
P577 | publication date | 2005-08-01 | |
P1433 | published in | Journal of Pharmacy and Pharmacology | Q10532762 |
P1476 | title | Determination of intraluminal theophylline concentrations after oral intake of an immediate- and a slow-release dosage form | |
P478 | volume | 57 |
Q50049609 | Absorption sites of orally administered drugs in the small intestine |
Q59285526 | Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole |
Q38073886 | Formulation approaches in mitigating toxicity of orally administrated drugs |
Q51472972 | Parallel monitoring of plasma and intraluminal drug concentrations in man after oral administration of fosamprenavir in the fasted and fed state. |
Q34139392 | Pharmacokinetics and Metabolism of Natural Methylxanthines in Animal and Man |
Q37700869 | Physiological parameters governing the action of pancreatic lipase |
Q46097645 | Postprandial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs. |
Search more.